vanzacaftor/tezacaftor/deutivacaftor
General
Genetic Implications: 
Pronunciation: 
van-zah-kaf-tor/tez-a-kaf-tor/due-tiv-a-kaf-tor
Trade Name(s)
- Alyftrek
Ther. Class.
cystic fibrosis therapy adjuncts
Pharm. Class.
transmembrane conductance regulator potentiators
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Vanzacaftor/tezacaftor/deutivacaftor." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580143/all/vanzacaftor_tezacaftor_deutivacaftor. 
Vallerand AHA, Sanoski CAC,  . Vanzacaftor/tezacaftor/deutivacaftor. Davis's Drug Guide. F.A. Davis Company; 2025. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580143/all/vanzacaftor_tezacaftor_deutivacaftor. Accessed October 31, 2025.
Vallerand, A. H., Sanoski, C. A., & ,  (2025). Vanzacaftor/tezacaftor/deutivacaftor. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580143/all/vanzacaftor_tezacaftor_deutivacaftor
Vallerand AHA, Sanoski CAC,  . Vanzacaftor/tezacaftor/deutivacaftor [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 October 31]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580143/all/vanzacaftor_tezacaftor_deutivacaftor.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -  vanzacaftor/tezacaftor/deutivacaftor
ID  -  3580143
A1  -  Sanoski,Cynthia A,
AU  -  Vallerand,April Hazard,
AU  -  ,,
BT  -  Davis's Drug Guide
UR  -  https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580143/all/vanzacaftor_tezacaftor_deutivacaftor
PB  -  F.A. Davis Company
ET  -  19
DB  -  Emergency Central
DP  -  Unbound Medicine
ER  -  

 Davis's Drug Guide
Davis's Drug Guide

